The Long Road to Understanding Heart Disease in Women
Heart disease is the leading cause of death among women in the United States, yet for decades the evidence guiding its prevention and treatment came almost entirely from studies of men. The field’ has evolved from an era in which women appeared in the cardiology literature mainly as caregivers to one in which gender disparities are recognized as a central variable in research and care. We describe how epidemiologic data, physician advocacy and federal research policy converged to bring women into clinical trials. The large body of work that followed suggest that many apparent outcome differences reflect differences in baseline risk and management rather than gender itself, and that the gap is narrowing. Persistent disparities in treatment, declining awareness and inequities by race and ethnicity remain. We present emerging priorities for research, clinical practice and public health.